$0.04
+0.00(4.26%)
Mkt Cap $2M
$0.03
$1.11
52-Week Range
At A Glance
1
Carisma Therapeutics, Inc., a biopharmaceutical company, develops chimeric antigen receptors (CAR) macrophages for the treatment of solid tumors.
2
Revenue is primarily driven by Option Right Collaboration Revenues (65.5%) and Milestones (34.5%).
3
No significant events in the past 90 days.
$2M
Market Cap
$53M
Revenue
$8M
Net Income
Employees46
Fundamentals
How The Business Makes Money
Revenue by Segment
Option Right Collaboration Revenues65.5%($4M)
Milestones34.5%($2M)
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0001485003
ISINUS14216R1014
CUSIP14216R101
Phone484 899 0326
Address3675 Market St., Philadelphia, PA, 19104, US
SEC EDGAR